DEPO-PROVERA: payments to doctors
Payments that named DEPO-PROVERA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Pfizer?
Pfizer reported the most payments naming DEPO-PROVERA. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $15K
- Providers
- 6
- Transactions
- 16
- Average per transaction
- $966
The per-transaction average — $966 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6 providers the average total is $2,576, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Pfizer | $15,456 | 100.0% |
Other products from Pfizer
The company that reported the most payments naming DEPO-PROVERA also reports against these.